1,1,2-trichloro-3,3,3-trifluoro-1-propene has been researched along with Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dekant, W; Kremling, E; Vamvakas, S | 1 |
1 other study(ies) available for 1,1,2-trichloro-3,3,3-trifluoro-1-propene and Kidney Diseases
| Article | Year |
|---|---|
Metabolic activation of the nephrotoxic haloalkene 1,1,2-trichloro-3,3,3-trifluoro-1-propene by glutathione conjugation.
Topics: Animals; Biotransformation; Chlorofluorocarbons; Female; Glutathione; Hydrocarbons, Halogenated; In Vitro Techniques; Kidney; Kidney Diseases; Liver; Male; Rats; Rats, Inbred Strains | 1989 |